Perspective Therapeutics, Inc. — Director's Dealing 2022

Aug 11, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Isoray, Inc. (ISR)
CIK: 0000728387
Period of Report: 2022-08-09

Reporting Person: Austin Mark John (VP Finance/Prin Fin&Acct Offic)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-09	Stock Options (right to buy)	$0.36	A	150000	Acquired	2032-08-09	Common Stock (150000)	Direct

Footnotes

F1: 25% vested as of 8/9/2022, and the remaining 75% will vest over the next three (3) years, commencing on 8/9/2023, until fully vested.